The Role of Class of Trade Research in Pharmaceutical Market Access

What Class of Trade Means in Distribution

Class of trade (CoT) categorizes customers based on their dispensing setting, ownership and health care role. Examples include retail pharmacies, hospitals/clinics, specialty pharmacies, mail-order pharmacies and integrated delivery networks (IDNs). Each class reflects a distinct mode of operation. For instance, retail pharmacies focus on walk-in outpatient dispensing, while hospital pharmacies serve both inpatients and outpatients under institutional contracts. Specialty pharmacies handle high-cost, complex therapies (e.g., oncology biologics) that often require patient monitoring and clinical support.¹ Many specialty medicines bypass retail channels and are distributed through specialty pharmacy networks. In practice, CoT is the segmentation logic that links these operational realities to business rules: It tells the system how to apply channel-specific pricing, discounts and rebate agreements. Without clear CoT distinctions, pricing strategies and contracts cannot reliably target the intended customer types.

Why Is There a Need for Continuous CoT Research?

Health care is dynamic: Mergers, acquisitions and organizational changes occur frequently. A small pharmacy may join a chain or a health system, a clinic might add a dispensing function, an IDN may spin off subsidiaries. Each structural change can affect how a site should be classified. For example, an independent pharmacy acquired by a hospital chain may become part of the hospital class and no longer qualify for independent pharmacy pricing. If the CoT database isn’t updated, downstream processes misapply contracts and pricing. Industry reports note that data quality lapses can cause major issues. One analysis found that poor data can cost 10% of annual revenue through wasted budgets and operational inefficiencies.² Thus, CoT research acts as an ongoing audit of customer data, ensuring that the internal system reflects the current reality. This alignment is essential for executing market access plans as intended.

What Are Common CoT Research Challenges?

CoT research faces several hurdles. A primary issue is identifier limitations. Standard IDs (like NPIs or store numbers) often fail to capture corporate relationships. A health system with many pharmacies might use one parent ID, so systems may not distinguish each site’s CoT. Investigators must dig into ownership records or local details to set the correct class.

Consolidation adds complexity. Health policy research observes that the industry is highly consolidated.³ Large hospital systems may operate outpatient retail pharmacies; PBMs may own specialty pharmacies; insurers may affiliate with clinics. These hybrid models blur category boundaries. For example, a hospital-affiliated outpatient pharmacy may have the outward appearance of a retail store, but follow hospital pricing agreements. Deciding its CoT requires context, not just a lookup table.

Data inconsistency is another challenge. Different sources (commercial databases, state licenses, internal lists) may disagree or lag. In practice, researchers often combine automated checks (for obvious mismatches) with manual review (for complex cases). This mixed approach helps reconcile discrepancies that automated tools alone cannot resolve.

What Is the Impact of Accurate Classification?

Accurate CoT classification yields immediate operational benefits. First, it drives pricing accuracy. Pricing tiers are typically tied to customer class, so any misclassification leads to wrong pricing. For example, treating a specialty pharmacy as a retail outlet could apply an inappropriate price or rebate. Over time, such mismatches can create significant revenue leakage or require costly corrections.

Second, it ensures correct contract eligibility. Many contracts have eligibility rules (e.g., “only independent pharmacies qualify” or “only hospital clinics may use this discount”). Misclassifying a customer might lead it to improperly receive contract benefits or miss out on benefits it deserves. Such mistakes often surface only during audits or reconciliations, by which time resources have been wasted.

Third, CoT accuracy safeguards compliance. Government programs like Medicaid rebates and the 340B program depend on precise entity identification. Under 340B rules, manufacturers must sell at deep discounts to covered entities (hospitals, clinics, etc.) as defined by statute.⁴ Entities must register and be verified with a 340B ID when purchasing. If a site’s CoT is wrong, it could incorrectly be treated as 340B-eligible or excluded, leading to audit risk.⁴ For example, a new hospital outpatient pharmacy must be reclassified to ensure its transactions follow the right 340B processes.

In operational terms, accurate CoT data smooth daily workflows. Accuracy reduces chargeback disputes, improves pricing consistency and enhances transparency in reports. In essence, it provides a solid foundation for all market access activities.

Why Does Data Governance Matter?

Given its critical role, CoT research requires robust governance. Key practices include:

• Standardized classification rules: Develop clear criteria for each CoT. For example, define exactly what constitutes a “hospital pharmacy” versus a “clinic dispensary.” This consistency prevents different teams from classifying the same site differently.
• Structured validation: Use automated tools to flag anomalies (like a pharmacy with changed ownership) and follow up with manual review for complex cases. Maintain documentation of decisions and sources used.
• Regular updates: Schedule periodic reviews of key customers, especially those likely to change (large chains, health systems, etc.). Monitor industry news for mergers or new facility openings.
• Cross-functional alignment: Ensure that market access, pricing and IT teams share the same CoT master file and definitions. Alignment reduces errors when data flows between systems.
• Data management frameworks emphasize governance, documentation and quality control to maintain reliable data.² In practice, these translate to disciplined processes and clear accountability around CoT data.

Conclusion

CoT research may be a behind-the-scenes function, but it is fundamental to market access success. By keeping customer classifications accurate and up to date, organizations can ensure that pricing, contracts and compliance measures are applied correctly. In today’s fast-changing health care landscape, continuous CoT validation and strong data governance are essential. Robust CoT research ultimately provides the clarity needed to translate strategy into reliable execution — enabling efficient pricing, contract integrity and regulatory compliance across complex pharmaceutical distribution networks.

References

1. Sood N, Shih T, Van Nuys K, Goldman D. The flow of money through the pharmaceutical distribution system. Schaeffer Center White Paper Series. USC Leonard D. Schaeffer Institute for Health Policy & Economics; 2017. DOI: https://doi.org/10.25549/hypg-r802
2. Kahn MG, Brown JS, Chun AT, et al. Transparent reporting of data quality in distributed data networks. eGEMs. 2015;3(1):1052. https://pmc.ncbi.nlm.nih.gov/articles/PMC4434997/
3. Robinson JC. Consolidation and the transformation of competition in health insurance. Health Aff (Millwood). 2004;23(6):11-24. https://pubmed.ncbi.nlm.nih.gov/15584099/
4. Health Resources and Services Administration. 340B drug pricing program. Accessed March 21, 2026. https://www.hrsa.gov/opa
5. Lesniewski S, Eady M. The importance of class of trade in master data governance. IQVIA; May 2023. Accessed March 21, 2026. https://www.iqvia.com/-/media/iqvia/pdfs/us/white-paper/2023/the-importance-of-class-of-trade-in-master-data-governance.pdf